✦ LIBER ✦

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

✍ Scribed by Alice T Shaw; Beow Y Yeap; Benjamin J Solomon; Gregory J Riely; Justin Gainor; Jeffrey A Engelman; Geoffrey I Shapiro; Daniel B Costa; Sai-Hong I Ou; Mohit Butaney; Ravi Salgia; Robert G Maki; Marileila Varella-Garcia; Robert C Doebele; Yung-Jue Bang; Kimary Kulig; Paulina Selaru; Yiyun Tang; Keith D Wilner; Eunice L Kwak; Jeffrey W Clark; A John Iafrate; D Ross Camidge

Book ID: 117785772
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 250 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70232-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multimodality therapy improves survival

Multimodality therapy improves survival in elderly patients with locally advanced non-small cell lung cancer—A retrospective analysis

✍ Harshita R. Paripati; Nina J. Karlin; Steven E. Schild; Sujay A. Vora; Amylou C. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 436 KB

Cost-Effectiveness Of Eml4-Alk Fusion Te

Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario

✍ Djalalov, S.; Hoch, J.S.; Beca, J.; Krahn, M.; Tsao, M.S.; Cutz, J.C.; Leighl, N 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

369 Timing of responses to crizotinib (P

369 Timing of responses to crizotinib (PF-02341066) in anaplastic lymphoma kinase (ALK)-positive patients with advanced non-small cell lung cancer (NSCLC)

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P-532 Survival rates in non-selected con

P-532 Survival rates in non-selected consecutive patients with advanced and metastatic non-small cell lung cancer (NSCLC): A retrospective analysis from a lung cancer center

✍ Martens, U.; Bludau, P.; Kaiser, P.; Schulte Mönting, J.; Digel, W. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Cost-Effectiveness of EML4-ALK Fusion Te

Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)

✍ Djalalov, S.; Beca, J.; Hoch, J.S.; Krahn, M.D.; Tsao, M.S.; Cutz, J.C.; Leighl, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

1166 PUBLICATION Effect of second-line c

1166 PUBLICATION Effect of second-line chemotherapy on survival of patients with advanced non-small cell lung cancer pre-treated with docetaxel-based front-line chemotherapy: a retrospective survival analysis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB